Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tian Yuan Investment, primarily operating as China Tian Yuan Investment Group, is a diversified investment holding company with a strategic focus on the healthcare and biotechnology sectors. Through its publicly traded subsidiary, China Tian Yuan Healthcare Limited, the group provides hospital management services, medical consulting, and operates aesthetic medicine clinics specializing in plastic surgery. The company is also a significant institutional investor in the biopharmaceutical industry, most notably holding a major stake in the vaccine developer Sinovac Biotech. Headquartered in Beijing and maintaining a strong presence in Hong Kong and Singapore, Tian Yuan Investment leverages its capital to drive growth in medical services and life science technologies across the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tian Yuan Investment.